Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,914,053
  • Shares Outstanding, K 49,292
  • Annual Sales, $ 90,100 K
  • Annual Income, $ -139,930 K
  • 60-Month Beta 0.70
  • Price/Sales 62.39
  • Price/Cash Flow N/A
  • Price/Book 9.19
Trade TWST with:

Options Overview Details

View History
  • Implied Volatility 63.29%
  • Historical Volatility 60.06%
  • IV Percentile 10%
  • IV Rank 13.57%
  • IV High 125.69% on 03/08/21
  • IV Low 53.50% on 11/23/20
  • Put/Call Vol Ratio 0.16
  • Today's Volume 71
  • Volume Avg (30-Day) 109
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 428
  • Open Int (30-Day) 299

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.79
  • Number of Estimates 4
  • High Estimate -0.76
  • Low Estimate -0.82
  • Prior Year -0.54
  • Growth Rate Est. (year over year) -46.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
101.59 +18.10%
on 08/23/21
123.66 -2.98%
on 09/10/21
+19.49 (+19.39%)
since 08/20/21
3-Month
90.53 +32.53%
on 08/17/21
136.87 -12.34%
on 06/30/21
+3.24 (+2.78%)
since 06/21/21
52-Week
62.37 +92.37%
on 09/24/20
214.07 -43.95%
on 01/21/21
+52.99 (+79.10%)
since 09/21/20

Most Recent Stories

More News
Illumina Ventures Closes $325 Million Fund

Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital...

ILMN : 434.76 (-0.74%)
SQZ : 14.79 (+2.42%)
TWST : 119.98 (+5.21%)
A Second Week of Declines as September Continues

A Second Week of Declines as September Continues

SATS : 25.83 (-0.54%)
ROKU : 319.00 (+0.95%)
PXD : 147.95 (-0.94%)
FISV : 106.21 (-1.04%)
TWST : 119.98 (+5.21%)
PACB : 27.41 (-2.07%)
NVTA : 31.79 (+3.11%)
CRSP : 117.25 (+0.67%)
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19

Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping...

TWST : 119.98 (+5.21%)
Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, and Twist Bioscience Corporation...

ACET : 7.05 (+2.32%)
TWST : 119.98 (+5.21%)
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Adicet Bio, Inc. (Nasdaq: ACET),...

TWST : 119.98 (+5.21%)
ACET : 7.05 (+2.32%)
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research...

TWST : 119.98 (+5.21%)
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust,...

TWST : 119.98 (+5.21%)
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies

CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through...

SLGC : 11.90 (+4.66%)
CMIIU : 11.22 (-5.40%)
TWST : 119.98 (+5.21%)
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) delivered earnings and revenue surprises of -7.89% and 7.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

TWST : 119.98 (+5.21%)
Twist Bioscience: Fiscal Q3 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Twist Bioscience Corp. (TWST) on Friday reported a loss of $40 million in its fiscal third quarter.

TWST : 119.98 (+5.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered...

See More

Key Turning Points

3rd Resistance Point 128.54
2nd Resistance Point 124.89
1st Resistance Point 122.44
Last Price 119.98
1st Support Level 116.34
2nd Support Level 112.69
3rd Support Level 110.23

See More

52-Week High 214.07
Fibonacci 61.8% 156.12
Fibonacci 50% 138.22
Fibonacci 38.2% 120.32
Last Price 119.98
52-Week Low 62.37

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar